Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature ...

AccuStem Sciences to introduce MSC blood test to lung cancer screening programmes in US: London, UK Tuesday, April 8, 2025, 11:00 Hrs [IST] AccuStem Sciences, Inc., a clinical sta ...

The global lung disease therapeutics market is on an impressive growth trajectory, projected to soar to USD 152,369.26 million by 2033, up from USD 83,398.60 million in 2023. This significant increase ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

GP practices who order more chest X-rays have fewer patients with cancers diagnosed at a late stage, researchers have found.

Six new medicines for conditions including cancer and liver disease will be made available for NHS Scotland patients.

A panel at Healthcare Heroes 2025 saw Cancer survivors reveal unconventional coping strategies A dancer performed through ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer ...

After health warnings about smoking but before the widespread use of vapes, millennials built a complex relationship with ...

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—celebrated 30 years of helping ...